High frequency oscillatory ventilation (HFOV) uses very high rates of small pressure variations around a constant distending pressure to ventilate the lungs. It relies on diffusion and other gas exchange mechanisms rather than conventional tidal volumes. HFOV is only used as a rescue therapy for failure of conventional ventilation in term or preterm infants with conditions like PPHN or MAS. Settings are adjusted based on oxygenation and ventilation, with the goal of maximizing lung volume while avoiding overinflation and trauma.
High frequency oscillatory ventilation (HFOV) is a type of mechanical ventilation that uses a constant distending pressure (mean airway pressure [MAP]) with pressure variations oscillating around the MAP at very high rates (up to 900 cycles per minute). This creates small tidal volumes, often less than the dead space.
HFO is a well debated topic but still man ICU physicians and respiratory therapists seem to be afraid of it and avoid this therapy. If in expert hands and utilized judicially it has saved lives and still has a lot of potential in it nit yet explored. Although this presentation is very long but it is drafted by keeping in ind to explain every thing about high frequency oscillatory ventilator to a beginner.
CLINICAL TEACHING ON BUBBLE CPAP: Introduction, Definition, History of development, Physiology of Bubble CPAP, Principle, Patient interface, equipments for bubble CPAP, indication and contraindication for bubble CPAP, essential of CPAP, CPAP machine, bubble cpap machine application, setting pressure, FiO2, oxygen flow, Monitoring adequacy and complications of bubble CPAP, Monitoring infant condition, weaning for Bubble CPAP, CPAP Failure, complications related to CPAP, Preventing complications, Nursing Care.
High frequency oscillatory ventilation (HFOV) is a type of mechanical ventilation that uses a constant distending pressure (mean airway pressure [MAP]) with pressure variations oscillating around the MAP at very high rates (up to 900 cycles per minute). This creates small tidal volumes, often less than the dead space.
HFO is a well debated topic but still man ICU physicians and respiratory therapists seem to be afraid of it and avoid this therapy. If in expert hands and utilized judicially it has saved lives and still has a lot of potential in it nit yet explored. Although this presentation is very long but it is drafted by keeping in ind to explain every thing about high frequency oscillatory ventilator to a beginner.
CLINICAL TEACHING ON BUBBLE CPAP: Introduction, Definition, History of development, Physiology of Bubble CPAP, Principle, Patient interface, equipments for bubble CPAP, indication and contraindication for bubble CPAP, essential of CPAP, CPAP machine, bubble cpap machine application, setting pressure, FiO2, oxygen flow, Monitoring adequacy and complications of bubble CPAP, Monitoring infant condition, weaning for Bubble CPAP, CPAP Failure, complications related to CPAP, Preventing complications, Nursing Care.
Patient ventilator interactions during mechanical ventilationDr.Mahmoud Abbas
Patient Ventilator Interaction during Mechanical Ventilation lecture presented by Dr.Lluis Blanch at Pulmonary Critical Care Egypt Meeting and Exhibition, January 2014. www.pccmegypt.com
Basic information on the Graphics displayed on the Ventilators. Prepared to educate about the graphics to train the professionals who work with Ventilators.
This presentation deals with the basic physics of human ventillation. I have made an effort to clarify most of the venti lingo , so as to make way for further discussions on ventilator use. Hope it turns out to be helpful for you. Thank you.
Cardio pulmonary interactions during Mechanical Ventilation Dr.Mahmoud Abbas
Cardio pulmonary interactions during Mechanical Ventilation lecture presented by Dr Lluis blanch at the Egyptian Critical care Summit, the leading medical event in Egypt
Presented by Dr.Nial Ferguson at Pulmonary Medicine Update Course held at Cairo, Egypt. Pulmonary Medicine Update Course is the leading Pulmonary Critical Care event in Egypt. Organized by Scribe www.scribeofegypt.com
Patient ventilator interactions during mechanical ventilationDr.Mahmoud Abbas
Patient Ventilator Interaction during Mechanical Ventilation lecture presented by Dr.Lluis Blanch at Pulmonary Critical Care Egypt Meeting and Exhibition, January 2014. www.pccmegypt.com
Basic information on the Graphics displayed on the Ventilators. Prepared to educate about the graphics to train the professionals who work with Ventilators.
This presentation deals with the basic physics of human ventillation. I have made an effort to clarify most of the venti lingo , so as to make way for further discussions on ventilator use. Hope it turns out to be helpful for you. Thank you.
Cardio pulmonary interactions during Mechanical Ventilation Dr.Mahmoud Abbas
Cardio pulmonary interactions during Mechanical Ventilation lecture presented by Dr Lluis blanch at the Egyptian Critical care Summit, the leading medical event in Egypt
Presented by Dr.Nial Ferguson at Pulmonary Medicine Update Course held at Cairo, Egypt. Pulmonary Medicine Update Course is the leading Pulmonary Critical Care event in Egypt. Organized by Scribe www.scribeofegypt.com
TEDx Manchester: AI & The Future of WorkVolker Hirsch
TEDx Manchester talk on artificial intelligence (AI) and how the ascent of AI and robotics impacts our future work environments.
The video of the talk is now also available here: https://youtu.be/dRw4d2Si8LA
The “How To” of BiVent
Created by: David Pitts II, RRT
Clinical Applications Specialist, Maquet
Birmingham, Alabama
Sponsored by Maquet, Inc – Servo Ventilators
An excellent tool to treat refractory hypoxia. Target audience are ICU junior physicians and Respiratory Therapists. It will take away the fear of "What is APRV?" from your hearts and you will feel ready to give it a try.
Mechanical Ventilation (MV) is almost always a challenging topic for ICU nurses and practitioners. In this presentation we are going to review and relearn basics of MV together.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
2. A type of mechanical ventilation that uses a constant
distending pressure (mean airway pressure [MAP]) with
pressure variations oscillating around the MAP at very
high rates (up to 900 cycles per minute).
It creats small tidal volumes, often less than the dead space.
HFOV may reduce lung injury.
3. Overcome to convention ventilation……
1. large pressure changes (the difference between PEEP and
PIP) create physiological tidal volumes
2. Gas exchange is dependent on bulk convection (expired gas
exchanged for inspired gas).
3. Ventilator induced lung injury (VILI) and chronic lung disease
(CLD
4. MECHANISM---
HFOV relies on alternative mechanisms of gas exchange such
as
• molecular diffusion,
• Taylor dispersion,
• turbulence,
• asymmetric velocity profiles,
• Pendelluft,
• cardiogenic mixing and
• collateral ventilation.
5. ONLY INDICATED AS A RESCUE THERAPY-
1. Failure of conventional ventilation in the term
infant (Persistent Pulmonary Hypertension of
the Newborn [PPHN], Meconium Aspiration
Syndrome [MAS]).
2. Air leak syndromes (pneumothorax,
pulmonary interstitial emphysema [PIE])
3. Failure of conventional ventilation in the
preterm infant (severe RDS, PIE, pulmonary
hypoplasia) or to reduce barotrauma when
conventional ventilator settings are high.
6. BE CAUTIOUS…..
not as yet proven to be of benefit in the elective or
rescue treatment of preterm infants with respiratory
dysfunction and may be associated with an
increase in intraventricular haemorrhage.
high airway pressures may result in impaired
cardiac output causing hypotension requiring
inotropic support or volume expansion
If there is no improvement with HFOV, consider
reverting to conventional ventilation.
7. TERMINOLOGY-
Frequency- High frequency ventilation rate
(Hz = cycles per second)
MAP- Mean airway pressure (cmH2O)
Power /Amplitude- delta P or power is the variation
around the MAP
PLATEAU PRESSURE (Ppause) – The plateau pressure
(PP) is the pressure applied to small airways and alveoli. It is
measured during an inspiratory pause on the ventilator. The
goal plateau pressure is
8. The goal plateau pressure to keep < 30 cm H2o to prevent
volutrauma secondary to overdistension of alveoli.
Without lung disease, peak inspiratory pressure (PIP) is only
slightly above the plateau pressure.
In cases of increased tidal volume or decreased pulmonary
compliance, the PIP and plateau pressure rise together
proportionately.
If the peak pressure rises with no change in plateau pressure,
increased airway resistance should be suspected or high
inspiratory gas flow rates
9. Normal curve – demonstrates normal PIP , Pplat , PTA (transairway pressure),
and Ti (inspiratory time). High Raw curve – A significant increase in the PTA is
associated with increased airway resistance. High Flow curve – the
inspiratory time is shorter than normal, indicating a higher inspiratory gas
flow rate. Decreased Lung Compliance curve – An increase in the plateau
pressure and a corresponding increase in the PIP is consistent with
decreased lung compliance
10. OXYGENTION AND VENTILATION--
-not dependent on each other as is the case with conventional
ventilation
Oxygenation is dependent on MAP and FiO2.
MAP provides a constant distending pressure equivalent to
CPAP. This inflates the lung to a constant and optimal lung
volume maximising the area for gas exchange and preventing
alveolar collapse in the expiratory phase
Ventilation (or CO2 elimination)-
is dependent on Amplitude/Power and to a lesser degree
frequency.
11. INITIAL SETTINGS ON HFOV
Optimal lung volume strategy-
(aim to maximise recruitment of alveoli).
Set MAP 2-3 cmH2O above the MAP on conventional
ventilation
MAP in 1-2 cmH2O steps until oxygenation improves
-Set frequency to 10 Hz
12. LOW VOLUME STRATEGY
(AIM TO MINIMISE LUNG TRAUMA)--
Set MAP equal to the MAP on conventional
ventilation
Set frequency to 10 Hz
Adjust amplitude to get an adequate chest wall
vibration.
13. Poor
Oxygenation
Over
Oxygenation
Under Ventilation Over Ventilation
Increase FiO2 Decrease FiO2 Increase Amplitude Decrease Amplitude
Increase MAP*
(1-2cmH2O)
Decrease MAP
(1-2cmH2O)
Decrease
Frequency**
(1-2Hz)
if Amplitude
Maximal
Increase
Frequency**
(1-2Hz)
if Amplitude
Minimal
Making adjustments once established on
HFOV-
14. CHEST RADIOGRAPH
Initial chest radiograph at 1-2 hrs to determine the baseline
lung volume on HFOV (aim for 8 ribs).
A follow-up chest radiograph in 4-6 hours is recommended to
assess the expansion.
Thereafter repeat chest radiography with acute changes in
patient condition.
15. WEANING-
Reduce FiO2 to <40% before weaning MAP (except
when over-inflation is evident).
Reduce MAP when chest radiograph shows evidence of
over-inflation (>9 ribs).
Reduce MAP in 1-2cm H2O increments to 8-10 cm H2O.
In air leak syndromes (low volume strategy), reducing
MAP takes priority over weaning the FiO2.
Wean the amplitude in 2-4cm H2O increments.
16. Do not wean the frequency
Discontinue weaning when MAP 8-10 cm H2O and Amplitude
20-25
Extubation-
If infant is stable, oxygenating well and blood gases are
satisfactory then infant could be extubated to CPAP or
switched to conventional ventilation. Discuss with consultant
17. SUCTIONING-
Suction is indicated for diminished chest wall movement
(chest wobble), elevated CO2 and/or worsening oxygenation
suggesting airway or ET tube obstruction, or if there are
visible/audible secretions in the airway.
Avoid in the first 24 hours of HFOV, unless clinically indicated